Position in AMGN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$3,582,888
+$281,313 QoQ
Shares Held
10,183
+1.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $104,513,791 across 18 Drug Manufacturers - General names. AMGN ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,405 | $27,965,606 | |
| 2 | ABBV |
AbbVie Inc.
|
103,875 | $22,591,773 | |
| 3 | JNJ |
Johnson & Johnson
|
80,406 | $19,654,442 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
75,984 | $10,589,890 | |
| 5 | MRK |
Merck & Co., Inc.
|
56,169 | $6,756,569 | |
| 6 | PFE |
Pfizer Inc
|
129,199 | $3,627,907 | |
| 7 | AMGN |
Amgen Inc
This page
|
10,183 | $3,582,888 | |
| 8 | NVS |
Novartis AG
|
16,366 | $2,499,906 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,582,888 | 10,183 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,301,575 | 10,087 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,936,855 | 10,407 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,735,420 | 9,797 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $3,093,379 | 9,929 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $2,445,845 | 9,384 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,246,265 | 10,075 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,877,664 | 9,210 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,598,684 | 9,140 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $2,578,931 | 8,954 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,526,344 | 9,400 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $1,852,756 | 8,345 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $2,438,048 | 10,085 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $2,434,410 | 9,269 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $2,090,359 | 9,274 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,156,854 | 8,865 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $2,099,239 | 8,681 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $1,728,894 | 7,685 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,493,653 | 7,024 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $1,784,250 | 7,320 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,839,949 | 7,395 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $1,588,977 | 6,911 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $2,278,036 | 8,963 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,942,307 | 8,235 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $1,602,783 | 7,906 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||